Latest news

Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology

Le “Prix Debiopharm/Valais pour les Sciences de la Vie” honore un chimiste valaisan pour son procédé électrochimique novateur

Debiopharm Signs License Agreement for Marketing of Salvacyl®/Moapar 3-month for Sexual Deviations

Clinical Update – Debio 025 in Hepatitis C – Presentation of Phase IIa Efficacy Results

Debiopharm and Airmid Sign Option and License Agreement for the Development of Debio 0824, an ShK Peptide for Autoimmune Disorders

Clinical Update – Debio 0614 (istaroxime) in Acute Heart Failure

Clinical Update – Debio 9902 SR in Alzheimer’s disease

Clinical update-Debio-9902 SR (ZT-1) implant for Alzheimer´s disease-First patients enroll in Phase II “BRAINz” study

Debiopharm and EPFL Establish An Oncology Chair